UC Berkeley researchers study chemical exposure for women firefighters
Scientists from UC Berkeley, UCSF and the Silent Spring Institute published a study Feb. 26 regarding the historically under-investigated topic of health risks for women firefighters.
UC Berkeley researchers study chemical exposure for women firefighters
Scientists from UC Berkeley, UCSF and the Silent Spring Institute published a study Feb. 26 regarding the historically under-investigated topic of health risks for women firefighters.
Berkeley Lab researchers create polymer that could help treat cancer
Researchers at the Lawrence Berkeley National Laboratory Molecular Foundry have created a type of polymer that may help fight diseases via photothermal therapy.
Berkeley Lab researchers create polymer that could help treat cancer
Researchers at the Lawrence Berkeley National Laboratory Molecular Foundry have created a type of polymer that may help fight diseases via photothermal therapy.
Report shows decrease in contaminants in East Bay drinking water
The East Bay Municipal Utility District recently reported a decrease in trihalomethane — a disinfection byproduct that forms after chlorine reacts with organic material in the water and has been linked to cancer — in its drinking water after new operational adjustments
Report shows decrease in contaminants in East Bay drinking water
The East Bay Municipal Utility District recently reported a decrease in trihalomethane — a disinfection byproduct that forms after chlorine reacts with organic material in the water and has been linked to cancer — in its drinking water after new operational adjustments
China’s State Intellectual Property Office, or SIPO, announced Monday that it will grant the University of California, in conjunction with the University of Vienna and Emmanuelle Charpentier, a patent for its CRISPR gene-editing technology.
China’s State Intellectual Property Office, or SIPO, announced Monday that it will grant the University of California, in conjunction with the University of Vienna and Emmanuelle Charpentier, a patent for its CRISPR gene-editing technology.